Egle Therapeutics
Biotherapies developer targeting regulatory T cells (Tregs) for immuno-oncology and autoimmune diseases.
B2X
Company Operating Status
Active
Country
CTO
Email Address
job@egle-tx.com
contact@egle-tx.com
0
Founded Date
January 1, 2020
Founder
Full Address
Pépinière Cochin Paris Santé 29 Rue du Faubourg St Jacques 75014 Paris, France
0
Headquarters
Latest Funding Round Date
March 17, 2025
Latest Funding Round Amount (USD)
10,000,000
Latest Funding Type
LinkedIn URL
Number of Employees (Ranges)
11 – 50
Phone Number
+33186640857
0
Pitchbook URL
Total Funding Amount (USD)
96,000,000
Official Website
Find more companies like Egle Therapeutics
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.